ZTSNYSELive delayed
$76.92
+1.57+2.08%
SourceCNBCAs ofJul 27, 2026, 8:10 PM
Delayed market data from CNBC. Not investment advice.
Zoetis is a healthcare name tracked on StockWatch with delayed quotes, charts, and related news. Home market: United States.
Key statistics
Delayed fundamentals for ZTS · Finnhub.
- Market cap
- $31.74B
- P/E (TTM)
- 11.87
- EPS (TTM)
- $6.0363
- Div. yield
- 1.64%
- 52-week range
- $71.47 – $160.48
- Volume
- —
- Avg volume
- 5.83M
Price history
OHLC candles for ZTS · 3mo · 1d · Yahoo Finance · delayed · EMA / RSI
-34.06%periodDirect mentions, stories that impact this name, and related market themes — with Impact Analysis on each headline.
DirectHigh impactGlobalMostly neutralGoogle News
ZTS Maintained by UBS -- Price Target Lowered to $85.00ZTS Maintained by UBS -- Price Target Lowered to $85.00 GuruFocusBroad market headline — check whether risk appetite shifts.
Watch: ZTS · UBS · .SPX · .FTSE
DirectHigh impactGoogle News
Zoetis (NYSE:ZTS): Dividend Quality Backed by Strong FundamentalsDirectHigh impactGoogle News
Zoetis Inc. $ZTS Shares Sold by Bank of Nova ScotiaDirectHigh impactGoogle News
ZTS Jun 2027 40.000 call (ZTS270617C00040000) stock price, news, quote and historyDirectHigh impactGoogle News
Zoetis Inc. $ZTS Shares Sold by Bradley Foster & Sargent Inc. CTDirectHigh impactGoogle News
19,059 Shares in Zoetis Inc. $ZTS Acquired by Delta Global Management LPDirectHigh impactGoogle News
How Lenivia’s Long-Acting Canine OA Launch At Zoetis (ZTS) Has Changed Its Investment StoryDirectHigh impactGoogle News
Unisphere Establishment Lowers Stock Position in Zoetis Inc. $ZTS